Robert Glassman - 15 May 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Reporting relationship: Director
Issuer ticker: PHVS
Reported as of: 15 May 2026
Net transaction value: -$298,245
SEC form: 4
Accepted by SEC: 19 May 2026, 18:48:21 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Marnus Nel, Attorney-in-Fact for Robert Glassman

Key filing fact

Robert Glassman filed Form 4 for Pharvaris N.V. (PHVS) on 19 May 2026.

Key facts

This page summarizes Robert Glassman's Form 4 filing for Pharvaris N.V. (PHVS).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 May 2026, 18:48.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$298,245.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001897890 Primary reporting owner

Glassman Robert

Relationship: Director
Address: 1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature: /s/ Marnus Nel, Attorney-in-Fact for Robert Glassman
Signature date: 19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,333
Change %: +35%
Price: $22.31^*
Shares after: 20,500
Date: 15 May 2026
Ownership: Direct

PHVS transaction

Common Stock

Sale

Transaction value: $159,091
Shares: -5,333
Change %: -26%
Price: $29.83
Shares after: 15,167
Date: 15 May 2026
Ownership: Direct
Footnotes: F1

PHVS transaction

Common Stock

Sale

Transaction value: $139,155
Shares: -4,667
Change %: -31%
Price: $29.82
Shares after: 10,500
Date: 15 May 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -5,333
Change %: -38%
Price: $0.000000^*
Shares after: 8,667
Date: 15 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,333
Exercise price: $22.31
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported price represents a weighted sale price for shares sold in multiple transactions on the reported date. The shares reported herein include shares of common stock acquired upon vestring of restricted stock units on various dates. The sales prices for the transactions ranged from $29.6550 to $29.92. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F2

The reported price represents a weighted sale price for shares sold in multiple transactions on the reported date. The shares reported herein include shares of common stock acquired upon vestring of restricted stock units on various dates. The sales prices for the transactions ranged from $29.7750 to $29.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

100% of the option vested on anniversary of grant, April 11th, 2025.